Brief: Orthofix Medical And CGBio Announce Strategic Partnership Agreement For Novosis rhBMP-2 Bone Graft Solutions
02/08/2022 12:32
Aug 2 (Reuters) - Orthofix Medical Inc OFIX.O :
* ORTHOFIX MEDICAL AND CGBIO ANNOUNCE STRATEGIC PARTNERSHIP
AGREEMENT FOR NOVOSIS RHBMP-2 BONE GRAFT SOLUTIONS
* ORTHOFIX MEDICAL - WILL CONDUCT CLINICAL STUDIES, OBTAIN
REGULATORY APPROVALS, AND COMMERCIALIZE NOVOSIS' RHBMP-2
TECHNOLOGY IN U.S. AND CANADA
* ORTHOFIX MEDICAL - CGBIO WILL RECEIVE AN UPFRONT PAYMENT
AND
POTENTIAL DEVELOPMENT MILESTONE PAYMENTS UPON ACHIEVEMENT OF
REGULATORY MILESTONES
Source text for Eikon: ID:nBw7HBc0Va
Further company coverage: OFIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orthofix Medical
See all newsOrthofix Medical Inc. reports results for the quarter ended June 30 - Earnings Summary
Orthofix Medical Q2 sales slightly beat estimates
Orthofix Medical Inc expected to post a loss of 41 cents a share - Earnings Preview
Orthofix Medical Q1 sales beat estimates, reaffirms FY outlook
Brief: Orthofix Medical Inc - Announces Strategic Realignment Of Spine Leadership Team